EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions

Emilia Hauza iD, Ivy J Mutai iD, Agnieszka Necel iD, Deus Kamya iD, Paulina Śliwka iD, Izabela Dusza iD, Alicja Węgrzyn iD, Aneta Skaradzińska iD

Clinical Microbiology Reviews · 10.09.2026 · 39 (3)

DOI: 10.1128/cmr.00048-26 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 10.09.2026. Verfasst von Emilia Hauza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Food Microbiology, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, …. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages, Skin Diseases, Skin Diseases, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin and soft tissue infections represent a major clinical challenge. This is particularly true given the rise in antimicrobial resistance, the increasing prevalence of chronic wounds, and the growing number of immunocompromised patients. Conventional antibiotic therapies are frequently compromised by multidrug-resistant pathogens, biofilm formation, and disruption of the skin microbiome, underscoring the urgent need for alternative or adjunctive antibacterial strategies. Bacteriophages, viruses that specifically infect and lyse bacteria, have re-emerged as promising therapeutic agents due to their high specificity, activity against antibiotic-resistant strains, and capacity to target biofilm-associated infections. This review provides a comprehensive overview of current advances in bacteriophage-based approaches for the treatment of cutaneous infections and skin disorders. We discuss the biological principles of phage therapy, its advantages and limitations, and the regulatory and manufacturing challenges associated with clinical translation. Particular emphasis is placed on topical and biomaterial-based phage delivery platforms, including hydrogels, nanocarriers, and adhesive wound dressings, designed to enhance phage stability, local bioavailability, and therapeutic efficacy. Furthermore, we summarize experimental and clinical evidence supporting the use of bacteriophages against the most clinically relevant skin pathogens. By integrating data from in vitro studies, animal models, clinical trials, and compassionate-use cases, this review highlights both the therapeutic potential and current limitations of phage-based interventions in dermatology. Collectively, the available evidence supports the use of bacteriophages as a viable component of future precision antimicrobial therapies for skin infections, while emphasizing the need for well-designed clinical trials, standardized production protocols, and optimized delivery systems to enable broader clinical adoption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyBacteriophagesSkin DiseasesSkin Diseases, BacterialSkin Diseases, InfectiousHumansAnimalsBiofilms

Stichwörter der Autor:innen

antibiotic resistancebacteriophage therapybacteriophageschronic woundsmelanomaskin and soft tissue infections (SSTIs)

Autor:innen und Institutionen

  • Department of Biotechnology and Food Microbiology, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, Wrocław, Poland.
  • Division of Microbiology and Infection, Becky Mayer Centre for Phage Research, University of Leicester, Leicester, United Kingdom.
  • Antimicrobial Resistance & Bacteriophage Biology Section, Kenya Institute of Primate Research, Karen, Nairobi, Kenya.
  • Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
  • University of East Anglia, Research Park, Norwich, United Kingdom.
  • Quadram Institute, Research Park, Norwich, United Kingdom.

ORCID-Profile: Emilia Hauza, Ivy J Mutai, Agnieszka Necel, Deus Kamya, Paulina Śliwka, Izabela Dusza, Alicja Węgrzyn, Aneta Skaradzińska

Zitieren

APA

Hauza, E., Mutai, I. J., Necel, A., Kamya, D., Śliwka, P., Dusza, I., Węgrzyn, A., & Skaradzińska, A. (2026). Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions. Clinical Microbiology Reviews, 39(3). https://doi.org/10.1128/cmr.00048-26

Vancouver

Hauza E, Mutai IJ, Necel A, Kamya D, Śliwka P, Dusza I, et al. Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions. Clinical Microbiology Reviews. 2026;39(3). doi:10.1128/cmr.00048-26

BibTeX
@article{Hauza2026,
  author = {Hauza, Emilia and Mutai, Ivy J and Necel, Agnieszka and Kamya, Deus and Śliwka, Paulina and Dusza, Izabela and Węgrzyn, Alicja and Skaradzińska, Aneta},
  title = {Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions},
  journal = {Clinical Microbiology Reviews},
  year = {2026},
  volume = {39},
  number = {3},
  doi = {10.1128/cmr.00048-26}
}
Kostenlos starten →